Imaging Services

 

European healthtech investor, MTIP leads investment in radiology platform, Hexarad

Swiss-based European healthtech investor, MTIP is leading a €13 million investment in radiology platform, Hexarad through its MTIP Fund II. It is making the investment as part of its ninth platform investment and as part of its efforts to empower innovation that improves lives by accelerating the adoption of digital technologies in healthcare. It will […]

CVC DIF acquires medneo UK

Netherlands-based infrastructure fund CVC DIF (formerly DIF Capital Partners) has acquired medneo UK, a UK-based imaging services company.

How AI is improving diagnostic imaging

Diagnostic imaging faces similar capacity and workforce issues as other areas of healthcare. But hundreds of start-ups are developing AI tools to ameliorate the situation. According to Antoine Jomier, CEO & Co Founder of Incepto Medica, a platform for imaging AI applications, there is at least a 30-40% time-saving for radiologists and as much as a seven percentage point EBITDA margin increase for providers at stake. Patients, payors and health systems at large also stand to benefit.

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.

IFM rumoured to be frontrunner in sale of Healius’ imaging division

Listed Australian primary care, pathology and diagnostics group Healius is selling its imaging branch, Lumus Imaging, as part of a restructuring plan to reduce the business complexity. According to local news sources, global institutional investment manager IFM Investors is now the frontrunner in the auction process.

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

HBI 2024 Day Three, Morning Briefing

The morning of day three of HBI 2024 included sessions on the right model for AI, ophthalmology, diagnostic imaging, nuclear medicine and occupational health.

Find Us